Estimated read time: Less than a minute
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.
(KSL News) A Utah laboratory may have found a way to halt the progression of Alzheimer's Disease. Myriad Genetics has been testing the drug Flurizan for more than two years.
Now, they say during clinical tests the drug has slowed the progression of the disease in some patients and brought it to a halt in others. Forty-two percent of test patients showed the drug improves or maintained their mental health for more than two years.
Once late-stage trials are complete, Flurizan will be submitted to the Food and Drug Administration for approval.
